{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:14:27Z","timestamp":1760044467683,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21ck0106667h0001"],"award-info":[{"award-number":["21ck0106667h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.humpath.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T13:18:25Z","timestamp":1647523105000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["CD3-and CD20-negative extramedullary non-Hodgkin leukemia\/lymphoma: a histopathological study of 118 cases"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-7920","authenticated-orcid":false,"given":"Akiko Miyagi","family":"Maeshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Makita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.03.005_bib1","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues. revised","first-page":"413","article-title":"Anaplastic large cell lymphoma, ALK-positive","author":"Falini","year":"2017"},{"key":"10.1016\/j.humpath.2022.03.005_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1479-5876-10-84","article-title":"CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: a matched case-control analysis in a single institution","volume":"10","author":"Li","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.humpath.2022.03.005_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13000-017-0606-7","article-title":"An unusual case of Epstein\u2013Barr virus-positive large B-cell lymphoma lacking various B-cell markers","volume":"12","author":"Nakatsuka","year":"2017","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1066896918784669","article-title":"Epstein\u2013Barr virus-positive CD20- and CD45-negative diffuse large B-cell lymphoma: a diagnostic challenge","volume":"27","author":"Starr","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1066896917735170","article-title":"De novo Unclassifiable CD20-negative diffuse large B-cell lymphoma: a diagnostic and therapeutic challenge","volume":"26","author":"AbdullGaffar","year":"2018","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1172\/JCI115044","article-title":"Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas","volume":"87","author":"Kanavaros","year":"1991","journal-title":"J Clin Invest"},{"year":"2017","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","key":"10.1016\/j.humpath.2022.03.005_bib7"},{"key":"10.1016\/j.humpath.2022.03.005_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.03.005_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/17474086.2015.1007862","article-title":"CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options","volume":"8","author":"Castillo","year":"2015","journal-title":"Expet Rev Hematol"},{"key":"10.1016\/j.humpath.2022.03.005_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.7150\/jca.17358","article-title":"IRF4\/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma","volume":"8","author":"Heo","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.humpath.2022.03.005_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1066896911418204","article-title":"MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma","volume":"20","author":"Ferenczi","year":"2012","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib12","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/PAS.0000000000000678","article-title":"Spindle cell melanoma and interdigitating dendritic cell sarcoma: do they represent the same process?","volume":"40","author":"Stowman","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y","article-title":"Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma","volume":"186","author":"Pilozzi","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/01.pas.0000155162.33044.4f","article-title":"B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in Merkel cell carcinoma and small cell carcinomas","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2559.2005.02317.x","article-title":"Loss of CD19 expression in B-cell neoplasms","volume":"48","author":"Masir","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.03.005_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/his.14300","article-title":"Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours","volume":"78","author":"Huettl","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.03.005_bib17","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. revised","first-page":"304","article-title":"EBV-positive diffuse large B-cell lymphoma, not otherwise specified (NOS)","author":"Nakamura","year":"2017"},{"key":"10.1016\/j.humpath.2022.03.005_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.humpath.2015.01.002","article-title":"CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosis","volume":"46","author":"Ma","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0090-1229(91)90128-W","article-title":"Expression of the low Mr isoform of CD45 (CD45RO) in B-cell non-Hodgkin\u2019s lymphomas","volume":"58","author":"Caldwell","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.humpath.2022.03.005_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.leu.2402126","article-title":"Triple-negative (CD3-\/CD4-\/CD8-) adult T cell leukemia\/lymphoma, histologically presenting as CD30 (Ki-1)-positive anaplastic large cell lymphoma with clonal Epstein\u2013Barr virus genome","volume":"15","author":"Kumura","year":"2001","journal-title":"Leukemia"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:33Z","timestamp":1758645573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":20,"alternative-id":["S0046817722000697"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.03.005","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD3-and CD20-negative extramedullary non-Hodgkin leukemia\/lymphoma: a histopathological study of 118 cases","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}